MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1136/gutjnl-2025-334911

Медицинская библиотека · Gut · 2025

Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold.

Tseng Tai-Chung, Huang Shang-Chin, Pan Mei-Hung, Liu Chun-Jen, Chen Chien-Jen, Yang Wan-Ting, Tsai Cheng-Hsueh, Su Tung-Hung, Yang Hung-Chih, Liu Chen-Hua, Chen Pei-Jer, Yang Hwai-I, Kao Jia-Horng

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Chronic hepatitis B (CHB) is a major global health concern primarily due to hepatocellular carcinoma (HCC) development.

OBJECTIVE

This study aimed to identify patients with inactive CHB with negligible HCC risk using hepatitis B surface antigen (HBsAg) levels, which is the key to define partial HBV cure.

DESIGN

Data from 2674 patients with inactive CHB (non-cirrhotic, hepatitis B e antigen negative, normal alanine transaminase (ALT), HBV DNA <2000 IU/mL) in the ERADICATE-B and REVEAL-HBV cohorts were analysed. The primary endpoint was HCC development, with HBsAg levels used to identify patients with annual HCC risk <0.2%. Results were validated using the NTUH-iMD cohort.

RESULTS

Over a median follow-up of 26.3 years, 76 patients developed HCC. Among 989 patients with inactive CHB with HBsAg<100 IU/mL, the annual HCC incidence was 0.08% (95% CI 0.05% to 0.13%), lower than those with HBsAg≥100 IU/mL (adjusted HR 0.35, 95% CI 0.21 to 0.61). Their HCC risk was lower than the recommended threshold for HCC surveillance and was close to the risk of the general population. Even for older patients recommended for HCC surveillance, those with HBsAg levels <100 IU/mL were associated with HCC risk lower than the surveillance threshold. Moreover, patients with inactive CHB with negligible HCC risk could be identified by combining HBsAg <100 IU/mL and normal ALT levels, without the need for HBV DNA testing, as validated in the NTUH-iMD cohort.

CONCLUSION

Serum HBsAg levels <100 IU/mL effectively identify patients with inactive CHB with negligible HCC risk and limited viral activity, which is important in optimising surveillance strategies and defining partial HBV cure.

Для цитирования: Tseng Tai-Chung, Huang Shang-Chin, Pan Mei-Hung, Liu Chun-Jen, Chen Chien-Jen, Yang Wan-Ting, Tsai Cheng-Hsueh, Su Tung-Hung, Yang Hung-Chih, Liu Chen-Hua, Chen Pei-Jer, Yang Hwai-I, Kao Jia-Horng. Hepatitis B surface antigen level identifies patients with inactive chronic hepatitis B from Asia with HCC risk below surveillance threshold.. Gut. 2025. DOI: 10.1136/gutjnl-2025-334911.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.